Trials / Completed
CompletedNCT01099124
Study of M2ES With Paclitaxel/Carboplatin (TC Regimen) in Advanced Non Small Cell Lung Cancer (NSCLC)
Single-center, Open Trail of Phase 1 of M2ES With TC Regimen in Advanced NSCLC
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 25 (actual)
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate safety and tolerance of M2ES with TC regimen in advanced NSCLC.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | M2ES | polyethylene glycol rh recombinant endostatin |
Timeline
- Start date
- 2009-12-01
- Primary completion
- 2011-07-01
- Completion
- 2011-09-01
- First posted
- 2010-04-06
- Last updated
- 2013-01-29
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01099124. Inclusion in this directory is not an endorsement.